Group One Trading’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.54M Buy
8,372
+5,803
+226% +$3M 0.01% 1460
2026
Q2
$1.39M Buy
+2,569
New +$1.45M ﹤0.01% 2569
2026
Q1
– Sell
-1,169
Closed -$582K – 8818
2025
Q4
$570K Buy
+1,169
New +$544K ﹤0.01% 3378
2025
Q2
– Sell
-6,838
Closed -$2.04M – 8707
2025
Q1
$2.11M Buy
+6,838
New +$2.34M 0.01% 1767
2024
Q3
– Sell
-545
Closed -$184K – 7414
2024
Q2
$174K Buy
+545
New +$144K ﹤0.01% 3520
2023
Q4
– Sell
-349
Closed -$78.8K – 8240
2023
Q3
$78.8K Buy
+349
New +$80.4K ﹤0.01% 4672
2023
Q2
– Sell
-8,196
Closed -$1.82M – 8250
2023
Q1
$1.84M Buy
+8,196
New +$2.02M 0.01% 1606
2020
Q2
– Sell
-30
Closed -$3.38K – 6205
2020
Q1
$3K Sell
30
-2,000
-99% -$190K ﹤0.01% 4911
2019
Q4
$179K Buy
+2,030
New +$179K ﹤0.01% 3258
2017
Q4
– Sell
-100
Closed -$12K – 5256
2017
Q3
$12K Buy
+100
New +$12.8K ﹤0.01% 4242
2016
Q1
– Sell
-100
Closed -$16K – 4973
2015
Q4
$16K Hold
100
– – ﹤0.01% 4017
2015
Q3
$13K Hold
100
– – ﹤0.01% 4207
2015
Q2
$17K Sell
100
-200
-67% -$36K ﹤0.01% 4108
2015
Q1
$52K Hold
300
– – ﹤0.01% 3344
2014
Q4
$39K Buy
+300
New +$38.7K ﹤0.01% 3535

Other funds holding UTHR

Group One Trading's UTHR Position: Q3 2026 in Review

Group One Trading increased its United Therapeutics (UTHR) stake by 226% in Q3 2026, buying an estimated $3M and bringing the position to 8,372 shares worth $4.54M. The position accounts for 0.01% of the portfolio, ranked #1460.

Group One Trading first reported a position in UTHR in Q4 2014 and has held it in 15 quarters since. 477 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Group One Trading held 8,372 shares of United Therapeutics worth $4.54M as of Q3 2026.
  • Group One Trading bought 5,803 United Therapeutics shares in Q3 2026, an estimated $3M.
  • United Therapeutics made up 0.01% of Group One Trading's portfolio in Q3 2026, its #1460 holding.
  • Group One Trading first reported a position in United Therapeutics in Q4 2014 and has held it in 15 quarters since.
  • 477 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.